6 research outputs found
Genetic Susceptibility Loci for Cardiovascular Disease and Their Impact on Atherosclerotic Plaques
BACKGROUND: Atherosclerosis is a chronic inflammatory disease in
part caused by lipid uptake in the vascular wall, but the exact underlying
mechanisms leading to acute myocardial infarction and stroke remain
poorly understood. Large consortia identified genetic susceptibility
loci that associate with large artery ischemic stroke and coronary
artery disease. However, deciphering their underlying mechanisms are
challenging. Histological studies identified destabilizing characteristics in
human atherosclerotic plaques that associate with clinical outcome. To
what extent established susceptibility loci for large artery ischemic stroke
and coronary artery disease relate to plaque characteristics is thus far
unknown but may point to novel mechanisms.
METHODS: We studied the associations of 61 established cardiovascular
risk loci with 7 histological plaque characteristics assessed in 1443 carotid
plaque specimens from the Athero-Express Biobank Study. We also
assessed if the genotyped cardiovascular risk loci impact the tissue-specific
gene expression in 2 independent biobanks, Biobank of Karolinska
Endarterectomy and Stockholm Atherosclerosis Gene Expression.
RESULTS: A total of 21 established risk variants (out of 61) nominally
associated to a plaque characteristic. One variant (rs12539895, risk allele
A) at 7q22 associated to a reduction of intraplaque fat, P=5.09×10−6
after correction for multiple testing. We further characterized this 7q22
Locus and show tissue-specific effects of rs12539895 on HBP1 expression
in plaques and COG5 expression in whole blood and provide data from
public resources showing an association with decreased LDL (low-density
lipoprotein) and increase HDL (high-density lipoprotein) in the blood.
CONCLUSIONS: Our study supports the view that cardiovascular
susceptibility loci may exert their effect by influencing the atherosclerotic
plaque characteristics
Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits
Few genome-wide association studies (GWAS) account for environmental exposures, like smoking, potentially impacting the overall trait variance when investigating the genetic contribution to obesity-related traits. Here, we use GWAS data from 51,080 current smokers and 190,178 nonsmokers (87% European descent) to identify loci influencing BMI and central adiposity, measured as waist circumference and waist-to-hip ratio both adjusted for BMI. We identify 23 novel genetic loci, and 9 loci with convincing evidence of gene-smoking interaction (GxSMK) on obesity-related traits. We show consistent direction of effect for all identified loci and significance for 18 novel and for 5 interaction loci in an independent study sample. These loci highlight novel biological functions, including response to oxidative stress, addictive behaviour, and regulatory functions emphasizing the importance of accounting for environment in genetic analyses. Our results suggest that tobacco smoking may alter the genetic susceptibility to overall adiposity and body fat distribution
Exploring the complex biology of the carotid atherosclerotic plaque
Cardiovascular disease (CVD) as result of atherosclerosis is a major cause of morbidity and mortality in many societies, despite the enormous research efforts in recent decades directed at prevention and improved treatment. Atherosclerosis of blood vessels can result in life threatening health complications including stroke, myocardial infarction, aortic dissection and leg amputation. When patients suffer from atherosclerosis of the carotid artery, the disease lesion may be removed by a carotid endarterectomy procedure. The Athero-Express biobank is the largest biobank in the world in which excised carotid artery specimens and blood samples are stored together with recorded patient health data. Subsequent extensive laboratory investigations of patient specimens have caused the Athero-Express to become an exceptionally well phenotyped cohort with unique value for the investigation of atherosclerotic cardiovascular disease and carotid artery disease in specific. The aim of this thesis was to explore the complex biology of the human carotid atherosclerotic plaque in order to provide a stepping stone towards improved risk prediction and precision drug development. To this end, we leveraged the unique properties of the Athero-Express Biobank to investigate carotid plaque parameters including histology and DNA methylation in relation to systemic risk factors such as sex, genetic variation, lipid levels, medication and smoking. This has shown that integration of genotyping, epigenotyping and phenotyping of the atherosclerotic disease lesion may yield meaningful new insights in cardiovascular disease
Gait Characteristics of Children with Spastic Cerebral Palsy during Inclined Treadmill Walking under a Virtual Reality Environment
Smoking is Associated to DNA Methylation in Atherosclerotic Carotid Lesions
Background: Tobacco smoking is a major risk factor for atherosclerotic disease and has been associated with DNA methylation (DNAm) changes in blood cells. However, whether smoking influences DNAm in the diseased vascular wall is unknown but may prove crucial in understanding the pathophysiology of atherosclerosis. In this study, we associated current tobacco smoking to epigenome-wide DNAm in atherosclerotic plaques from patients undergoing carotid endarterectomy. Methods: DNAm at commonly methylated sites (cytosine-guanine nucleotide pairs separated by a phospho-group [CpGs]) was assessed in atherosclerotic plaque samples and peripheral blood samples from 485 carotid endarterectomy patients. We tested the association of current tobacco smoking with DNAm corrected for age and sex. To control for bias and inflation because of cellular heterogeneity, we applied a Bayesian method to estimate an empirical null distribution as implemented by the R package bacon. Replication of the smoking-associated methylated CpGs in atherosclerotic plaques was executed in the second sample of 190 carotid endarterectomy patients, and results were meta-analyzed using a fixed-effects model. Results: Tobacco smoking was significantly associated to differential DNAm in atherosclerotic lesions of 4 CpGs (false discovery rate <0.05) mapped to 2 different genes (AHRR, ITPK1) and 17 CpGs mapped to 8 genes and RNAs in blood. The strongest associations were found for CpGs mapped to the gene AHRR, a repressor of the aryl hydrocarbon receptor transcription factor involved in xenobiotic detoxification. One of these methylated CpGs were found to be regulated by local genetic variation. Conclusions: The risk factor tobacco smoking associates with DNAm at multiple loci in carotid atherosclerotic lesions. These observations support further investigation of the relationship between risk factors and epigenetic regulation in atherosclerotic disease
Genetic Susceptibility Loci for Cardiovascular Disease and Their Impact on Atherosclerotic Plaques.
BACKGROUND: Atherosclerosis is a chronic inflammatory disease in part caused by lipid uptake in the vascular wall, but the exact underlying mechanisms leading to acute myocardial infarction and stroke remain poorly understood. Large consortia identified genetic susceptibility loci that associate with large artery ischemic stroke and coronary artery disease. However, deciphering their underlying mechanisms are challenging. Histological studies identified destabilizing characteristics in human atherosclerotic plaques that associate with clinical outcome. To what extent established susceptibility loci for large artery ischemic stroke and coronary artery disease relate to plaque characteristics is thus far unknown but may point to novel mechanisms. METHODS: We studied the associations of 61 established cardiovascular risk loci with 7 histological plaque characteristics assessed in 1443 carotid plaque specimens from the Athero-Express Biobank Study. We also assessed if the genotyped cardiovascular risk loci impact the tissue-specific gene expression in 2 independent biobanks, Biobank of Karolinska Endarterectomy and Stockholm Atherosclerosis Gene Expression. RESULTS: A total of 21 established risk variants (out of 61) nominally associated to a plaque characteristic. One variant (rs12539895, risk allele A) at 7q22 associated to a reduction of intraplaque fat, P=5.09×10-6 after correction for multiple testing. We further characterized this 7q22 Locus and show tissue-specific effects of rs12539895 on HBP1 expression in plaques and COG5 expression in whole blood and provide data from public resources showing an association with decreased LDL (low-density lipoprotein) and increase HDL (high-density lipoprotein) in the blood. CONCLUSIONS: Our study supports the view that cardiovascular susceptibility loci may exert their effect by influencing the atherosclerotic plaque characteristics